Invesco Ltd. Amicus Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 2,550,058 shares of FOLD stock, worth $23.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,550,058

Previous 2,553,013 0.12%

Holding current value

$23.9 Million

Previous $25.3 Million 7.54%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$9.55 - $12.09 $28,220 - $35,725	-2,955 Reduced 0.12%	2,550,058 $27.2 Million
Q2 2024 Aug 13, 2024	BUY	$9.04 - $11.75 $16.2 Million - $21 Million	1,787,125 Added 233.34%	2,553,013 $25.3 Million
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $6.86 Million - $8.55 Million	600,212 Added 362.28%	765,888 $9.02 Million
Q4 2023 Feb 12, 2024	SELL	$9.97 - $14.52 $7.5 Million - $10.9 Million	-752,043 Reduced 81.95%	165,676 $2.35 Million
Q3 2023 Nov 13, 2023	BUY	$11.78 - $13.86 $1.77 Million - $2.09 Million	150,641 Added 19.64%	917,719 $11.2 Million
Q2 2023 Aug 11, 2023	SELL	$10.72 - $13.3 $1.78 Million - $2.2 Million	-165,651 Reduced 17.76%	767,078 $9.63 Million
Q1 2023 May 12, 2023	BUY	$10.91 - $13.54 $1.22 Million - $1.51 Million	111,630 Added 13.6%	932,729 $10.3 Million
Q4 2022 Feb 13, 2023	BUY	$9.89 - $12.7 $941,082 - $1.21 Million	95,155 Added 13.11%	821,099 $10 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $5.56 Million - $7.22 Million	566,417 Added 355.06%	725,944 $7.58 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $46,070 - $82,232	7,395 Added 4.86%	159,527 $1.71 Million
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $51,971 - $82,205	-6,587 Reduced 4.15%	152,132 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $106,193 - $134,526	-10,814 Reduced 6.38%	158,719 $1.83 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $178,636 - $241,997	20,439 Added 13.71%	169,533 $1.62 Million
Q2 2021 Aug 17, 2021	BUY	$8.71 - $10.72 $299,902 - $369,111	34,432 Added 30.03%	149,094 $1.44 Million
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $15.7 Million - $40.6 Million	-1,701,167 Reduced 93.69%	114,662 $1.13 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $326,768 - $603,806	-24,259 Reduced 1.32%	1,815,829 $41.9 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $6.39 Million - $7.88 Million	495,707 Added 36.87%	1,840,088 $26 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $835,391 - $1.48 Million	94,288 Added 7.54%	1,344,381 $20.3 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $34.7 Million - $58.3 Million	-5,228,451 Reduced 80.7%	1,250,093 $11.6 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $3.9 Million - $5.6 Million	521,167 Added 8.75%	6,478,544 $63.1 Million
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $324,537 - $536,174	-40,466 Reduced 0.67%	5,957,377 $47.8 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $12.2 Million - $16 Million	1,111,022 Added 22.74%	5,997,843 $74.9 Million
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $4.49 Million - $6.23 Million	-447,210 Reduced 8.38%	4,886,821 $66.5 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $44.7 Million - $71.7 Million	5,334,031 New	5,334,031 $51.1 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.63B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account